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Provocation Testing in Noncardiac Chest Pain 
TIMOTHY T. NOSTRANT, M.D., Ann Arbor, Michigan 
The ability to reproduce chest pain and to 
identify the esophagus as the source of this 
pain are the major reasons why provocation 
testing has become standard in the evaluation 
of patients with noncardiac chest pain. Recent 
studies that challenge the validity of perform- 
ing provocation tests have polarized experts 
into two camps: those who would abandon 
such testing because of its low sensitivity and 
low specificity, and those who would use test- 
ing judiciously because of moderate increases 
in diagnostic yield, Use of 24-hour pH and 
pressure testing has shown a high number of 
chest pain events associated with acid reflux in 
patients with positive cholinergic stimulation 
tests and esophageal dysmotility, as well as 
pain with esophageal dysmotility in patients 
with positive acid infusion tests, Mechanisms 
of esophageal chest pain are not known. All 
provocation agents can decrease coronary flow 
reserve (i.e., induce microvascular angina), 
thus raising the question of a cardiac source of 
pain even in patients with positive presumed 
esophageal provocation. Acid infusion, cholin- 
ergic stimulation, and balloon distention are 
discussed in light of 24-hour pH and pressure 
monitoring. Esophageal distention and the role 
of acid in inducing chest pain are emphasized. 
The role of stress, the use of defined stressors 
to induce chest pain, and altered pain percep- 
tion as a final common pathway for chest pain 
are examined. 
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P revocation testing has become standard in the evaluation of patients with noncardiac chest 
pain [l-3]. Acid infusion, cholinergic stimulation, 
and balloon distention are the most commonly used 
provocation tests. Provocation testing allows the 
physician to reproduce the spontaneous pain felt by 
the patient, thereby increasing the power of provo- 
cation testing over standard manometry, which 
rarely connects pain with a motility abnormality. 
Controversy over the role of provocation testing 
stems from a lack of knowledge of the mechanisms 
for spontaneous and provoked chest pain and from 
rapid proliferation of new pain provocation methods 
that do not have adequate confnmation from labo- 
ratories [4-61. Other factors that complicate the 
interpretation of studies of noncarcliac chest pain 
and provocation testing include problems in patient 
selection and an inadequate database of normal 
esophageal motility and acicl exposure over long 
periods of observation. This article will review the 
controversies about provocation testing, discuss 
data on commonly used provocation agents ancl how 
they produce chest pain, and summarize how prov- 
ocation testing is best used in evaluating patients 
with noncardiac chest pain. 
CONTROVERSIES IN PROVOCATION TESTING 
The role of provocation testing is still poorly de- 
fined. Experts have decriecl the rapid proliferation 
of provocation tests without adequate corrobora- 
tion and the lack of proof that a positive provocation 
test implicates the esophagus as the cause of chest 
pain [4]. Microvascular angina has been proposed as 
the cause of chest pain in most patients with pre- 
sumed noncarcliac chest pain [4,7,8]. Others have 
agreed that esophageal dysmotility is an uncommon 
cause of chest pain, but, because acid has produced 
chest pain [5,9], investigators have identified gas- 
troesophageal acid reflux as a cause of chest pain in 
35-50% of patients with chest pain and normal cor- 
onary arteries [5,61. Other stimuli may also be im- 
portant in producing chest pain. Distention through 
stimulation of mechanoreceptors may be an ex- 
tremely common mechanism. Both esophageal dys- 
motility (by producing esophageal distention proxi- 
mal to a functionally contracted segment) and acid 
reflux (by bolus esophageal distention) may pro- 
duce pain through this mechanism rather than 
through smooth muscle contraction or acid sensitiv- 
ity, respectively [2,3,10]. 
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Why is there so much controversy about the role 
of the esophagus in patients with chest pain and the 
role of provocation testing in eliciting this pain? The 
basis of the controversy lies in three questions: (a) 
What is the mechanism of esophageal chest pain? 
(b) Is provoked chest pain the same as spontaneous 
chest pain? (c) Does a positive provocation test im- 
plicate the esophagus as the cause of chest pain? 
What Are the Mechanisms of Esophageal Chest Pain? 
The precise abnormality in esophageal function 
that produces chest pain is not known. For a num- 
ber of reasons, abnormalities in contraction ampli- 
tude and duration alone are unlikely causes: 
(a) they are frequently found in baseline recordings 
of asymptomatic patients [11,121; (b) treatment 
that lowers pain scores in patients with noncardiac 
chest pain does so without changing esophageal 
motility parameters [13,14]; (c) calcium channel 
antagonists (which effectively decrease both esoph- 
ageal body ancl lower esophageal sphincter pres- 
sures) frequently are ineffective in treating pre- 
sumed esophageal chest pain [14,151; (cl) sponta- 
neous high-amplitucle, long-cluration esophageal 
contractions .have been associated with chest pain 
but occur as frequently without pain [X,17]; (e) an 
absence of contraction may be seen during chest 
pain [18,19]; and (f) esophageal dysmotility in asso- 
ciation with chest pain occurs in only lo-25% of 
documented chest pain events cluring 24-hour 
esophageal pH and pressure recordings [20-221. 
Acid reflux into the esophagus may induce chest 
pain by several mechanisms. Chemoreceptor stimu- 
lation by hydrogen ions is presumed to be the most 
common cause. In one study, acid-induced micro- 
vascular damage occurred early in the course of 
acid esophageal injury, before microscopically visi- 
ble inflammation was present, ancl it increased with 
increasing acid loads [23]. This acid-induced dam- 
age may be associated with pain. Of 25 sympto- 
matic gastric acid reflux patients, all had pain re- 
produced during infusion of highly acidic solutions 
(pH 1.0) , whereas 50% reported pain after infusions 
of less acidic solutions (pH as high as 6) [24]. Other 
factors that influenced the incidence of chest pain 
were duration of acid exposure and the number of 
previous chest pain events: of patients with chest 
pain, 80% had acid exposure times >lO minutes and 
previous chest pain events. This raises the possibil- 
ity that acid may induce pain by other mechanisms 
[24,25-J, such as volume distention of the esophagus 
or by increasing visceral pain perception. 
The most common cause of chest pain during acid 
infusion was initially thought to be dysmotility [26]. 
Simultaneous and spontaneous distal esophageal 
contractions of increased amplitude and duration 
were seen in most patients during Bernstein test- 
ing [2G]. However, this has not been reproduced by 
other investigators [27,281. Changes in amplitude 
and duration of contraction occurred equally in nor- 
mal subjects and in patients with symptomatic re- 
flux [27], and 24-hour pH and pressure monitoring 
studies have shown that most acid-induced chest 
pain events occur without dysmotility [9,20-221. 
Other mechanisms for chest pain during esophageal 
acid perfusion, such as interactions between pepsin 
and other barrier breakers, as well as coronary ancl 
esophageal ischemia, have had some experimental 
support but have either not been studied acle- 
quately in chest pain patients or are unlikely to be 
sufficient to produce chest pain [5,101. Recent stud- 
ies have demonstrated that chest pain patients hacl 
a higher pain response after acid infusion (35%) 
than after cholinergic stimulation with eclropho- 
mum (20%) [25]. However, 11 of the 12 patients re- 
sponding to edrophonium also responded to acid in- 
fusion, suggesting a common mechanism for pain 
other than chemoreceptor stimulation by hydrogen 
ions. 
Distention of the esophagus is an effective means 
of producing chest pain. Chest pain patients may be 
more sensitive to distention than controls. Chest 
pain patients clevelop more chest pain and at lower 
distention volumes than do normal subjects [29]. 
This clistention-incluced pain occurred without a 
change in amplitude or duration of esophageal con- 
traction proximal or distal to the distended seg- 
ment. 
Enhanced pain perception as a cause of chest pain 
has received increasing support [10,13,30,31]. Al- 
terecl pain perception could bring together under a 
single mechanism all the known ways of producing 
esophageal pain, such as acid, inflammation, dys- 
motility, balloon distention, as well as food and 
temperature induction. Recent studies using esoph- 
ageal balloon distention and electrical stimulation 
have shown definite and reproducible cerebral 
evoked potentials after stimulation [31-331. Clinical 
studies in patients with chest pain are awaitecl. 
Is Provoked Esophageal Chest Pain the Same as 
Spontaneous Chest Pain? 
Baseline recordings of the esophagus in patients 
with chest pain have shown a high percentage of 
patients with abnormal baseline motility (25-33%). 
Of these patients, nonspecific esophageal dys- 
motility and “nutcracker esophagus” were ob- 
served in X30% [11,12]. Provocation testing in- 
creases the diagnostic yield by 20-55%, with cho- 
linergic stimulation accounting for 80-90% of the 
increase, whereas acid perfusion increases the 
number of patients with definable esophageal chest 
pain by only 7% [11,12,341. Unfortunately, baseline 
dysmotility does not predict a higher percentage of 
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patients with provoked chest pain, raising the ques- 
tion of the role of baseline esophageal dysmotility in 
producing chest pain [5,6,341. Using criteria sug- 
gested by Lee et al [35], investigators reported that 
amplitude of contraction exceeded baseline levels 
by 20 mm Hg in 8’7% of chest pain patients during 
pain but also in 69% of chest pain patients who did 
not develop pain and 68% of normal subjects 
[35,36]. No clear-cut level of abnormality in any 
esophageal manometric parameter discriminatecl 
between patients with and without pain. Only dura- 
tion of contraction consistently has been shown to 
increase after cholinergic stimulation; a lack of in- 
creases in duration of contraction after cholinergic 
stimulation is highly predictive of a chest pain pa- 
tient who will not develop chest pain during provo- 
cation testing [11,12,36]. Some investigators have 
abandoned ’ esophageal contractive response and 
use only pain reproduction as an end point for a 
positive provocation test [5,6,36]. 
Use of 24-hour pH and pressure monitoring al- 
lows physiologic evaluation of both normal subjects 
and patients with chest pain [17,20-221. In one 
study, 36% of pain events were explained by abnor- 
mal motility or acid reflux, with the latter account- 
ing for two thirds of all esophageal pain events [21]. 
Janssens and coworkers [221 have used 24-hour 
monitoring to show that up to 60% of pain events 
have a potential esophageal origin. In these stud- 
ies, however, a high percentage of patients (33%) 
had true angina, and an even higher percentage 
(44%) had unequivocal esophageal symptoms such 
as heartburn or dysphagia. The incidence of exer- 
cise-induced angina pectoris in the study by Jans- 
sens and coworkers [22] was 33%, with 44 of 60 pa- 
tients having symptoms of heartburn or dysphagia. 
When standard esophageal testing was compared 
with 24-hour pH and pressure monitoring, there 
was discordance of testing [37]. Patients with nut- 
cracker esophagus were equally likely to have dys- 
motility or acid as causes for their spontaneous 
chest pain events, whereas patients with normal 
manometry were significantly more likely to have 
chest pain related to acid reflux. A positive acid 
perfusion test was significantly associated with 
abnormal pressure events, while a positive edro- 
phonium test was more commonly associated with 
acid reflux pain. Thus, ambulatory monitoring may 
give completely different mechanisms for chest 
pain than those predicted by standard motility test- 
ing and esophageal acid perfusion studies, despite 
the fact that patients felt the provoked pain was 
identical to their spontaneous pain. Others feel that 
standard manometry, Bernstein testing, and 24- 
hour pH and pressure monitoring add little to chest 
pain evaluation (~20% yield overall) [20]. 
Does a Positive Provocation Test Implicate the 
Esophagus? 
A positive acid perfusion or cholinergic stimula- 
tion study has been presumed to indicate an esoph- 
ageal origin for pain [2-61. Mellow et al [381 first 
suggested that esophageal acid perfusion could in- 
duce coronary ischemia. Of patients with infre- 
quent reflux symptoms, 64% had angina during acid 
perfusion tests, and 56% of patients with coronary 
disease who developed chest pain during esopha- 
geal acid infusion could not distinguish that pain 
from their usual angina [381. In 10 of 12 patients 
with known coronary artery disease, exertional 
angina threshold was lowered significantly after 
acid infusion compared with saline controls [39]. 
The decreased threshold was more pronounced in 
patients with regular esophageal symptoms than in 
those without symptoms. In addition, both esopha- 
geal dysmotility and acid decrease coronary flow 
reserve, which may lead to “microvascular angina,” 
a syndrome that may be associatecl with chest pain 
[40]. During atria1 pacing and ergonovine stimula- 
tion, 83% of patients with esophageal clysmotility 
had abnormal coronary flow resistance and 67% 
developed angina with provocation [40,41]. Thus, 
clysmotility may produce chest pain by decreased 
coronary blood flow, and both esophageal dys- 
motility and coronary flow resistance may be a gen- 
eralized disorder of smooth muscle function. As 
stated, however, mechanisms of esophageal chest 
pain are not known. 
SPECIFIC PROVOCATION TESTS 
Food and Temperature 
Some patients state that certain foods or cold liq- 
uids precipitate their chest pain. Mellow showed 
that food ingestion could produce esophageal dys- 
motility not evident at baseline in chest pain pa- 
tients [42]. Dysmotility was enhanced if bethane- 
chol, a cholinergic agonist, was coadministerecl. 
The rate of positive examinations in patients with 
food-associated symptoms was lOO%, even though 
standard esophageal manometry was negative in all 
patients. In a retrospective analysis of 100 consecu- 
tive patients with chest pain, dysphagia, or both, 
food ingestion produced significantly more dys- 
motility in patients with dysphagia than did water 
swallows (79 vs 43%), and dysphagia was repro- 
duced in 47% of patients [43]. Chest pain rarely was 
reported after food ingestion. 
Low-temperature liquids also can incite chest 
pain. Unlike food ingestion, which enhances 
nonperistaltic contractions and incomplete lower 
esophageal sphincter relaxation, ice water most 
commonly produces chest pain and a complete ab- 
sence of motor activity in affected persons [43,44]. 
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Esophageal cooling brings on a transient state of 
relative paralysis in the distal esophagus and lower 
esophageal sphincter, with increased nonperistaltic 
waves, reduced peristaltic strength, increased du- 
ration and reduced velocity of distal esophageal 
contractions, ancl reducecl lower esophageal sphinc- 
ter pressure [19,45,46]. In animal models, these 
factors have all been associatecl with esophageal 
distention. Esophageal wall ischemia may be an- 
other mechanism. A selective clecrease in mucosal 
blood flow could allow increased acid back-diffusion 
or altered sensory receptor function. The time for 
esophageal wall rewarming after cold water chal- 
lenge was longer in 9 patients with esophageal 
spasm or nutcracker esophagus than in 21 normal 
subjects (90 vs 44 seconds); only 1 patient had a 
normal esophageal rewarming time [47]. Age or 
gender did not affect the results. Whether true 
mucosal ischemia occurs awaits confirmation by 
techniques allowing study of blood flow in clifferent 
layers of the human esophagus. As with food inges- 
tion, cold liquicl precipitation of chest pain is seen in 
~5% of chest pain patients [45,46]. 
Hyperosmolarity and stimulation of esophageal 
chemoreceptors as a mechanism for esophageal 
chest pain were fust reported by Lloycl [4’7]. Hy- 
pertonic saline, sucrose, and, most recently, hyper- 
tonic glucose [48,49] have been used as provocation 
tests for chest pain, but comparative studies have 
shown that they clearly are inferior to standard 
agents [48,49]. 
Acid infusion Test (Bernstein Test) 
The acid infusion (Bernstein) test is used to cle- 
tect patients with presumed gastroesophageal re- 
flux and acid-induced pain [50,51]. Acid infusion 
studies are negative if the patient has no pain, posi- 
tive if the usual pain is reproduced, and indetermi- 
nate if some discomfort occurs but does not simu- 
late the patient’s spontaneous pain [50-531. Relief 
with saline is frequently used to confirm the diagno- 
sis but requires a much longer examination and 
may be falsely negative even in patients with docu- 
mented reflux [53]. Behar et al showed that, using 
heartburn as the end point, sensitivity and specific- 
ity approached 80% [52]; patients with esophagitis 
were invariably positive. False-positive rates of 
lo-20% were seen in both normal subjects and pa- 
tients with peptic ulcer disease. 
Recent studies cast doubt that positive acid infu- 
sion testing is either specific or sensitive for gastro- 
esophageal reflux [2,9,25,50]. Acid infusion can in- 
duce chest pain in normal subjects with no definable 
reflux during 24-hour pH testing [9]. Angina1 chest 
pain also can be induced by acid. Sensitivity of acid 
infusion with chest pain as the end point has an inci- 
dence of 7-64% [50-531. Hewson et al [9,50] clemon- 
stratecl that acid sensitivity was uncommon in 100 
consecutive chest pain patients (19%), while abnor- 
mal 24-hour pH reflux parameters and/or a positive. 
symptoms inclex were positive in 46% and 60%, re- 
spectively; these results limit the role of acid infu- 
sion testing in laboratories with 24-hour monitoring 
capability. Preliminary stuclies in our laboratory 
have inclicated that 24-hour pH monitoring is more 
preclictive for antacid treatment response than 
Bernstein testing. Relief of chest pain after 4 weeks 
of acid-suppressive therapy (omeprazole 20 mg 
every morning) was the reference for response. 
Patients with endoscopically visible esophagitis or 
positive distal esophageal biopsies were excluded. 
A total of 70 patients with persistent noncardiac 
chest pain were treated empirically; clinical re- 
sponse occurred in 53 patients (76%) at 4 weeks. Of 
responders, 48 (90%) had abnormal 24-hour pH 
monitoring, but only 24 (45%) had a positive Bern- 
stein test. Of the 17 patients not responding to 
empiric therapy, only 1 hacl abnormal pH monitor- 
ing and 5 had a positive Bernstein test. Bernstein 
testing frequently may be positive in patients with 
clear-cut esophageal dysmotility as a cause of their 
chest pain. Of the 5 patients with a positive Bern- 
stein test, 4 had positive bethanechol provocation 
with clocumented simultaneous esophageal dys- 
motility. 
Edrophonium Stimulation 
Edrophonium chloride, an anticholinesterase, is 
the current cholinergic stimulant of choice for test- 
ing patients with noncarcliac chest pain. In normal 
subjects, chest pain following edrophonium stimu- 
lation rarely is seen (<4%), but a rapid bolus infu- 
sion of edrophonium induces chest pain in 25-33% 
of patients with noncardiac chest pain. If both chest 
pain and manometric changes are required, the re- 
ported positivity rates clecline to 3-9% [11,54,55], 
except in a study by Lee et al, who found a higher 
percentage of positive patients even if manometric 
changes were required (34%) [35]. Their use of dry 
swallows may have increased perceived motility 
abnormalities, since dry swallows frequently pro- 
duce simultaneous ancl repetitive contractions 
[35,36]. A standard 10 mg dose rather than a fixed 
dose per kilogram will produce a greater duration 
of contraction, a slightly increased level of signifi- 
cant side effects (compared to a fixed dose), but a 
lower frequency of significant side effects when 
compared with bethanechol (33 vs 45%, respec- 
tively) [55]. 
Edrophonium has no effect on coronary artery 
diameter and decreases cardiac work, making a car- 
diac source for edrophonium-induced pain unlikely 
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[54,55]. Several investigators have confirmed these 
results [2,3,25,351. 
One of the few studies comparing edrophonium 
with other provocation tests evaluated acid infu- 
sion, bethanechol, and edrophonium in consecutive 
patients with noncardiac chest pain 1341. Edropho- 
nium was superior although the yield was low 
(18%); acid infusion was the least useful examina- 
tion. Chest pain without manometric abnormalities 
was as frequent as that with motility abnormalities. 
In contrast, in a study of GO consecutive patients, 
De Caestecker et al [25] demonstrated that acid in- 
fusion had a higher yield than edrophonium. Most 
responders to edrophonium also responded to acicl 
infusion. Even those with primary motility dis- 
orders responded to acid infusion, suggesting a 
common cause for pain production during acid infu- 
sion and edrophonium challenge 1251. 
Patient selection strongly influences the rate of 
positive responses to eclrophonium. Higher rates of 
positive responses are reportecl in coronary care- 
unit patients [5G], those with exercise-induced 
chest pain [2,12,56,57], those with ergonovine posi- 
tivity during cardiac catheterization [56-621, and 
those with positive gastrointestinal symptoms 
[2,3,11], whereas patients with no associated gas- 
trointestinal symptoms had the lowest yielcl of posi- 
tive results [12,25]. The presence of baseline esoph- 
ageal dysmotility did not predict a higher rate of 
positive responses than that in patients with nor- 
mal baseline motility [23]. 
At this time, edrophonium should be considerecl 
the standard cholinergic provocation agent because 
of its low side-effect profile and ease of administra- 
tion. Unfortunately, cholinergic stimulation at the 
currently accepted doses will give low yielcls of pos- 
itive responses and may be replaced by more physi- 
ologic systems such as 24-hour pH and pressure 
monitoring ancl esophageal balloon distention. 
Bethanechol. 
Bethanechol, a cholinergic agonist, was first de- 
scribed as inducing motor abnormalities in patients 
with documented primary esophageal motility dis- 
orders such as achalasia and diffuse esophageal 
spasm [2,3,62,63]. Subcutaneous injection of betha- 
nechol at doses of 40-50 pg/kg induces chest pain in 
12-33% of chest pain patients [2,3]. Our group re- 
ported positive pain reproduction in 77% after two 
subcutaneous doses of bethanechol(50 pg/kg) [12]. 
Why was the yield in our study so much greater 
than that in previous studies and greater than in a 
recent study using a single dose of bethanechol80 
/-@kg F-341? 
Retrospective analysis identified three factors 
that may have influenced the results. The first was 
patient selection. Patients with true angina and 
those with positive ergonovine testing have a 
higher rate of positive responses to cholinergic 
stimuli such as bethanechol. Using the criteria of 
Constant [65], 63 of 86 patients with chest pain hacl 
true angina pectoris, and 50 patients had positive 
ergonovine tests cluring cardiac catheterization 
without definable coronary spasm. A total of 55 of 
the 63 patients with true angina hacl positive re- 
sponses to bethanechol, and 48 of 50 patients with 
positive ergonovine testing had a positive bethane- 
chol test. Of the remaining 17 patients with chest 
pain, 8 had atypical angina and 9 had nonanginal 
chest pain (>2 nonanginal components). Chest pain 
was reproduced in 4 of 8 patients with atypical an- 
gina ancl 3 of 9 patients with nonanginal chest pain 
(50 and 33%, respectively). 
A second factor was medication dosage. The 
mean bethanechol close for each injection was 4.5 
mg, for a mean total close of 9.0 mg. Positive re- 
sponses occurrecl in 48 of 51 patients receiving ~10 
mg. 
A third factor was the definition of a positive re- 
sponse. Dysmotility was defined as a mean mano- 
metric score cluring each 15-minute observation 
period greater than the mean +2 standard devia- 
tions of the score for normal subjects for each be- 
thanechol dosage, rather than a definable motility 
change at the exact time of chest pain. Using this 
definition, dysmotility was notecl in 80% of patients 
before pain induction. Other authors have empha- 
sizecl that motility parameters in the period preced- 
ing chest pain may be more predictive of a positive 
chest-pain response than motility at the time of 
chest pain [2,3,20-221. 
We have examined 850 consecutive chest pain 
patients with bethanechol stimulation using similar 
patient selection criteria. The overall response rate 
has been 42%. Our standard dosage of bethanechol 
is now two 5 mg doses. Side-effect profiles have 
remained the same. There have been three cases of 
symptomatic bradycardia requiring atropine and 
one case of symptomatic hypotension. Pam at the 
injection site is universal but tolerable in almost all. 
Chest pain or abdominal discomfort requiring atro- 
pine occurs in only 10% of patients and is limited 
almost entirely to true angina patients. In 10 tested 
cases, simultaneous esophageal and heart record- 
ings during cardiac catheterization have shown no 
significant alterations in heart rate, blood pressure, 
and electrocardiogram recordings, and no signifi- 
cant coronary artery narrowing. Richter has stated 
that bethanechol may induce an acute stress that 
precipitates pain by nonesophageal mechanisms 
[2,3], but the lack of chest pain in normal subjects 
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and the low incidence of chest pain in patients with 
acid-induced pain make this explanation less plausi- 
ble. 
Ergonovine Stimulation Tests 
Ergonovine maleate has been used during car- 
diac catheterization to induce chest pain by bring- 
ing on focal spasm in epicardial coronary vessels. 
The incidence of esophageal dysmotility is high in 
ergonovine-positive patients [58-611. Caution is 
needed in using ergonovine because of the risk of 
coronary spasm and reports of myocardial infarc- 
tion after testing [58]. Comparative studies be- 
tween ergonovine and edrophonium have shown no 
advantage for ergonovine [59,60]. Ergonovine, 
therefore, cannot be recommended for standard 
esophageal testing. 
Balloon Distention 
Graded esophageal balloon distention was rein- 
troducecl in 1986 as a provocation test for noncar- 
disc chest pain [29]. This test allows a titratable 
means of provoking pain without the use of sys- 
temic agents. Barish et al [29] demonstrated that 
48% of patients had reproduction of their pain at a 
balloon volume 18 mL; this balloon distention vol- 
ume did not procluce pain in any normal subjects. 
The diagnostic yield of balloon distention (58 mL 
balloon volume) was twice that after acid infusion 
and eclrophonium (48 vs 24%). A total of 11 of 12 
patients positive by acid infusion or eclrophonium 
testing were positive by balloon clistention, and an 
additional 13 patients were positive only with bal- 
loon distention. The test was reproducible, with 
patients having recurrent pain at the same balloon 
volume +l mL. There were no electrocarcliogram 
abnormalities, and the pain immediately disap- 
peared with balloon deflation. 
The mechanism for pain production was initially 
thought to be increased esophageal muscle tone 
[29,65-681. For both primates and humans, 
intraballoon dPldV (ratio of change in pressure to 
change in volume) curves showed linear changes at 
lower balloon volumes; incremental changes cle- 
creased with increasing balloon volumes [66-691. 
No clistinctive pattern was seen in chest pain pa- 
tients. Bethanechol and eclrophonium stimulation 
did not change the difference between dPldV 
curves (a crucle measure of esophageal muscle tone) 
with balloon distention ex vivo or in vivo; thus, be- 
thanechol and edrophonium most likely do not pro- 
duce chest pain by increased esophageal muscle 
tone [65-681. Other authors have shown a high pos- 
itivity rate (87.5%) with balloon distention in pa- 
tients with nutcracker esophagus [‘70]. Patients 
with baseline dysmotility may have a higher posi- 
tive response rate to esophageal balloon distention 
compared with the total population of noncardiac 
chest pain patients. 
Location of the balloon in the esophagus during 
distention cletermines the pattern of manometric 
changes as well as the number of patients positive 
with balloon insufflation [66,67]. Amplitude ancl 
duration of contraction of the esophagus, as well as 
pain scores, are higher proximal to balloon clisten- 
tion 16 cm above, compared with 6 cm above, the 
lower esophageal sphincter [66]. Atropine, an anti- 
cholinergic, significantly decreased oracl contrac- 
tion amplitudes after distal esophageal clistention 
but hacl no effect when balloon insufflation occurred 
16 cm above the lower esophageal sphincter [66,671. 
Atropine decreased pain scores after clistal esopha- 
geal distention but not after proximal balloon insuf- 
flation. There was no discernible pattern of balloon 
dPldV curves at each clistention site. The authors 
concluded that oracl contractions had some effect on 
pain perception, but esophageal muscle tone did not 
appear to be a major factor in distention-induced 
pain. Studies of the stomach using true Barostat 
balloons, which record continuous muscle tone, 
have shown differences compared with noncontinu- 
ous dP/dV curves, and true muscle tone may not be 
measured by static dPldV curves [71,721. 
Stress Provocation Testing 
A direct relationship between emotional state 
and esophageal motility was suggested by the ob- 
servation that patients with esophageal dysmotility 
hacl a high incidence of psychiatric abnormalities 
(predominantly depression and anxiety neurosis) 
[2,3,30,31,73]. Patients with chest pain or irritable 
bowel syndrome have a greater fixation on gastro- 
intestinal symptoms ancl frequently relate stress to 
gastrointestinal upset [31]. Patients using moocl- 
altering medications have lower pain scores com- 
parecl with patients taking placebo clespite no 
change in esophageal manometric parameters [13]. 
The effects of stress on visceral afferent input are 
being studiecl. 
Anderson et al [74] recently demonstrated that 
both noise stress ancl difficult cognitive problems 
induced motor abnormalities in patients with non- 
cardiac chest pain and in normal subjects. Cogni- 
tive problem-solving producecl a greater increase in 
contraction amplitucle and anxiety behavior than 
did noise stress. Patients with nutcracker esopha- 
gus had greater increases in contraction amplitude 
than normal subjects or patients with normal base- 
line motility. These investigators also showed that 
the level of symptom severity is greater in patients 
SYMPOSIUM ON UNEXPLAINED CHEST PAIN / NOSTRANT 
May 27, 1992 The American Journal of Medicine Volume 92 (suppl 5A) 5A-SlS 
with documented acid reflus during times of stress 
.compared with no stress; however, there was no 
objective change in any reflux barameter induced 
by stress. Patients with the highest level5 of anxi- 
ety measured by psychological testing had higher 
levels of reflux severity compared with low-anxiety 
patients. Autonomic hyperactivity (increased blood 
pressure, pulse, and anxiety state) was consistently 
observed during stress times in both high-anxiety 
and low-anxiety groups [73-761. 
From these studies and others, it seems apparent 
that patients with noncardiac chest pain, irritable 
bowel synclrome, and possibly nonulcer dyspepsia 
have a decreased threshold for visceral sensory 
stimulation [78,79]. A total of 56% of noncardiac 
chest pain patients were found to have symptoms of 
irritable bowel syndrome [31]. Visceral afferent 
endings in the gastrointestinal tract are involvecl in 
vasodilation, increases in vascular permeability, 
contraction and relaxation of smooth muscle, ancl 
depolarization of autonomic efferent neurons in 
paravertebral ganglia [78]. Electrical stimulation 
of mesenteric nerves to the intestine elicits a choli- 
nergic contraction that is resistant to guanethi- 
dine but sensitive to the sensory neurotoxin capsai- 
tin [78,79], suggesting that afferent input could 
have terminals on intrinsic cholinergic neurons [77]. 
This intrinsic cholinergic activity could allow 
changes in esophageal motility and visceral sensa- 
tion [78-811 and could partially explain the pain- 
producing effects of all provocation agents includ- 
ing acid, cholinergic stimulation, and esophageal 
distention. Recent studies in normal subjects have 
demonstrated reproducible cortical evoked poten- 
tials that may be the end point of afferent-induced 
perception [32,33]. 
CONCLUSION 
Esophageal provocation testing has a useful place 
in the evaluation of patients with noncarcliac chest 
pain. Pain induction assures the physician and pa- 
tient of a good prognosis in those patients with nor- 
mal coronary arteries. In long-term follow-up stucl- 
ies, patients with a negative cardiac evaluation ancl 
positive provocation test(s) for presumed esopha- 
geal pain have a low mortality, less disability if the 
source is known, and use meclical resources to a 
lesser degree than those without a definable pain 
source [82]. Where the pain is coming from and how 
it is produced are still matters of serious debate. 
Specific provocation tests should be individual- 
izecl to the patient. Patients with food- or tempera- 
ture-induced symptoms might best be served by 
motility testing after these stimuli. The role of acid 
perfusion is decreasing with the advent of 24hour 
pH testing, which is significantly more sensitive 
and specific and appears to predict clinical re- 
sponse. Cholinergic stimulation using edrophonium 
or bethanechol allows some increased cliagnostic 
yield but with significant sicle effects. Balloon clis- 
tention offers a more .physiologic stimulus that cap- 
tures most if not all patients with positive choliner- 
gic ancl acid perfusion tests ancl gives incremental 
positive results. The effects of balloon clistention on 
pain perception should be studied. Recent studies 
using cerebral ancl spinal evokecl potentials offer a 
promising new way to look at pain perception at the 
spinal column or cortical level. Modification of spi- 
nal and cortical input may be the best means of re- 
ducing pain in patients with noncarcliac chest pain. 
Further research into the mechanisms of esopha- 
geal chest pain and further technical developments 
in prolonged monitoring most likely will disclose 
the cause(s) of noncardiac chest pain and offer posi- 
tive solutions to this problem. 
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